← Back to guidelines
Cardiology103 papers

Frontotemporal dementia

Last edited: 4/14/2026

Overview

Frontotemporal dementia (FTD) is a heterogeneous group of neurodegenerative disorders primarily affecting individuals under 65 years, characterized by behavioral, language, and executive dysfunction 2.

Diagnosis

  • Clinical Assessment: Essential for diagnosis, often challenging to distinguish from Alzheimer's disease (AD) and other dementias 1.
  • Brain Perfusion SPECT: Limited diagnostic value; sensitivity 56%-88%, specificity 51%-93% for FTD vs. AD; improves accuracy when combined with clinical data 1.
  • Neurofilament Light Chain (NfL): Shows potential as a biomarker for differentiating FTD from healthy controls, AD, and psychiatric disorders; higher levels in specific FTD subtypes like semantic dementia 3.
  • Management

  • No Specific Drug Treatments: Currently, no FDA-approved medications specifically target FTD symptoms 12.
  • Supportive Care: Focus on managing behavioral symptoms, cognitive decline, and maintaining quality of life 2.
  • Genetic Counseling: Recommended for families with hereditary forms, particularly those with VCP mutations 7.
  • Special Populations

  • Hereditary Forms: VCP mutations present with high penetrance for FTD (100% in one family, 70% in another) alongside variable features like Paget disease of bone 7.
  • Key Recommendations

  • Combine Clinical Assessment with Brain Perfusion SPECT for Challenging Diagnoses: When clinical differentiation is difficult, SPECT can be considered to enhance diagnostic accuracy (Evidence: Moderate 1).
  • Utilize Neurofilament Light Chain (NfL) Biomarkers for Differentiation: NfL levels can aid in distinguishing FTD from other dementias and psychiatric disorders (Evidence: Moderate 3).
  • Consider Genetic Testing and Counseling in Suspected Hereditary Cases: Especially for families with a history of VCP mutations, to guide prognosis and management (Evidence: Expert opinion 7).
  • References

    1 Athanasio BS, Oliveira ACS, Pedrosa AL, Borges RS, Neto AOM, Oliveira RA et al.. The role of brain perfusion SPECT in the diagnosis of frontotemporal dementia: A systematic review. Journal of neuroimaging : official journal of the American Society of Neuroimaging 2024. link 2 Bandopadhyay R, Gatt A, Lashley T. Advances in the Understanding of Frontotemporal Dementia. Cells 2023. link 3 Karantali E, Kazis D, Chatzikonstantinou S, Petridis F, Mavroudis I. The role of neurofilament light chain in frontotemporal dementia: a meta-analysis. Aging clinical and experimental research 2021. link 4 Morris JK. Immunity at the forefront of the brain: A new genetic model of FTD. Science translational medicine 2017. link 5 Schönbach C, Horton P, Yiu SM, Tan TW, Ranganathan S. GIW and InCoB, two premier bioinformatics conferences in Asia with a combined 40 years of history. BMC genomics 2015. link 6 Pijnenburg YA. The roots of social inappropriateness in frontotemporal dementia. Journal of neurology, neurosurgery, and psychiatry 2007. link 7 Guyant-Maréchal L, Laquerrière A, Duyckaerts C, Dumanchin C, Bou J, Dugny F et al.. Valosin-containing protein gene mutations: clinical and neuropathologic features. Neurology 2006. link 8 Pleasure SJ, Selzer ME, Lee VM. Lamprey neurofilaments combine in one subunit the features of each mammalian NF triplet protein but are highly phosphorylated only in large axons. The Journal of neuroscience : the official journal of the Society for Neuroscience 1989. link

    Original source

    1. [1]
      The role of brain perfusion SPECT in the diagnosis of frontotemporal dementia: A systematic review.Athanasio BS, Oliveira ACS, Pedrosa AL, Borges RS, Neto AOM, Oliveira RA et al. Journal of neuroimaging : official journal of the American Society of Neuroimaging (2024)
    2. [2]
      Advances in the Understanding of Frontotemporal Dementia.Bandopadhyay R, Gatt A, Lashley T Cells (2023)
    3. [3]
      The role of neurofilament light chain in frontotemporal dementia: a meta-analysis.Karantali E, Kazis D, Chatzikonstantinou S, Petridis F, Mavroudis I Aging clinical and experimental research (2021)
    4. [4]
      Immunity at the forefront of the brain: A new genetic model of FTD.Morris JK Science translational medicine (2017)
    5. [5]
      GIW and InCoB, two premier bioinformatics conferences in Asia with a combined 40 years of history.Schönbach C, Horton P, Yiu SM, Tan TW, Ranganathan S BMC genomics (2015)
    6. [6]
      The roots of social inappropriateness in frontotemporal dementia.Pijnenburg YA Journal of neurology, neurosurgery, and psychiatry (2007)
    7. [7]
      Valosin-containing protein gene mutations: clinical and neuropathologic features.Guyant-Maréchal L, Laquerrière A, Duyckaerts C, Dumanchin C, Bou J, Dugny F et al. Neurology (2006)
    8. [8]
      Lamprey neurofilaments combine in one subunit the features of each mammalian NF triplet protein but are highly phosphorylated only in large axons.Pleasure SJ, Selzer ME, Lee VM The Journal of neuroscience : the official journal of the Society for Neuroscience (1989)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG